Aster Capital Management (Difc) LTD Syndax Pharmaceuticals Inc Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 248 shares of SNDX stock, worth $4,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
248Holding current value
$4,124% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
225Shares Held
88.2MCall Options Held
953KPut Options Held
653K-
Black Rock Inc. New York, NY7.91MShares$131 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$97.2 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$82.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$81.3 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$68.3 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $941M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...